Remodulin

Active Ingredient(s): Treprostinil
FDA Approved: * May 21, 2002
Pharm Company: * UNITED THERAP
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Remodulin Overview

Treprostinil (marketed under the trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension.[1] Treprostinil is a synthetic analog of prostacyclin (PGI2). The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso. Contents 1 Medical uses 2 Adverse effects 3 Mechanism of action 4 Pharmacokinetics 5 Dosage and admini...

Read more Remodulin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Treprostinil

Recent Remodulin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Treprostinil
  • Injection: 100mg, 10mg/ml, 1mg/ml, 2.5mg/ml, 200mg, 20mg, 50mg, 5mg/ml
  • Solution: 0.6mg/ml, 100mg/20ml (5mg/ml), 200mg/20ml (10mg/ml), 20mg/20ml (1mg/ml), 50mg/20ml (2.5mg/ml)
  • Tablet, Extended Release: 0.125mg, 0.25mg, 1mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Remodulin: (4 results)

Sorted by National Drug Code
  • 66302-101 Remodulin 20 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-102 Remodulin 50 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-105 Remodulin 100 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-110 Remodulin 200 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation

Other drugs which contain Treprostinil or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA